Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through two segments, Reinforcement Materials and Performance Chemicals. The company offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial produ…
An institutional-grade, numbers-driven thesis on CBT — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of August 16, 2026, TradersQuant's model rates Cabot Corp. (CBT) 56/100 with a 12-month base-case forecast of $94.00 — +7.0% versus the current price of $87.88. Cabot Corp. trades at $87.88 in the Basic Materials sector, with a market capitalisation of $4.54B. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month analyst consensus price target for CBT is $94.00, implying +7.0% versus the current price. The model's 12-month scenario range runs from $88.80 (bear) to $115.10 (bull), with a base case of $99.13.
On the fundamentals, Cabot shows a P/E of 24.3, trailing revenue of $3.71B, revenue growth of -7.0% YoY, a dividend yield of 2.07%. This page also tracks CBT's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
CBT currently carries a TradersQuant composite score of 56/100, which we read as a neutral-to-watch signal. The Wall-Street analyst consensus is "Buy". Our 12-month price target of $94.00 implies +7.0% from $87.88. This is research, not financial advice — always combine it with your own judgement.
The analyst consensus price target for CBT is $94.00, about +7.0% versus the latest price of $87.88. Consensus is based on 15 analysts.
TradersQuant's 12-month model forecast for CBT is a base case of $99.13, ranging from $88.80 (bear) to $115.10 (bull), an expected return of +12.8%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for CBT over the next 12 months is $99.13 in the base case (bear $88.80, bull $115.10), versus today's price of $87.88. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for CBT — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates CBT's fair value at $94.00, implying +7.0% of expected upside versus the current price.
Yes — Cabot pays a dividend yielding 2.07% (about $1.82 per share annually).
Data and model outputs are for research only and are not financial advice. Figures update continuously.
